Featured essay
503B Outsourcing Facilities & FDA Drug Shortages: Can CDMOs Close the Supply Gap?Modern Catalyst The U.S. drug shortage crisis has reached a structural inflection point. As of 2025, the FDA's shortage inventory reflects persistent gaps in critical injectable medications, oncology agents, and antimicrobials—many of which have remained unavailable for months o…
Read full essay